tinidazole has been researched along with HIV Coinfection in 2 studies
Tinidazole: A nitroimidazole alkylating agent that is used as an antitrichomonal agent against TRICHOMONAS VAGINALIS; ENTAMOEBA HISTOLYTICA; and GIARDIA LAMBLIA infections. It also acts as an antibacterial agent for the treatment of BACTERIAL VAGINOSIS and anaerobic bacterial infections.
tinidazole : 1H-imidazole substituted at C-1 by a (2-ethylsulfonyl)ethyl group, at C-2 by a methyl group and at C-5 by a nitro group. It is used as an antiprotozoal, antibacterial agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galiwango, RM | 1 |
| Bagaya, B | 1 |
| Mpendo, J | 1 |
| Joag, V | 1 |
| Okech, B | 1 |
| Nanvubya, A | 1 |
| Ssetaala, A | 1 |
| Muwanga, M | 1 |
| Kaul, R | 1 |
| Mank, TG | 1 |
| Zaat, JO | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Testing the Ability of a Microbiome - Focused Intervention to Reduce HIV Susceptibility in Ugandan Men[NCT03412071] | 125 participants (Anticipated) | Interventional | 2017-12-07 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for tinidazole and HIV Coinfection
| Article | Year |
|---|---|
Diagnostic advantages and therapeutic options for giardiasis.
Topics: Animals; Antiprotozoal Agents; Female; Giardiasis; HIV Infections; Humans; Metronidazole; Pregnancy; | 2001 |
1 trial available for tinidazole and HIV Coinfection
| Article | Year |
|---|---|
Protocol for a randomized clinical trial exploring the effect of antimicrobial agents on the penile microbiota, immunology and HIV susceptibility of Ugandan men.
Topics: Administration, Cutaneous; Administration, Oral; Anti-Infective Agents; Bacteria; CD4-Positive T-Lym | 2019 |